In this episode of the Psychedelic Medicine Podcast, Balázs Szigeti, PhD, joins to discuss his research on the intersection of microdosing psychedelics and the placebo effect. Dr. Szigeti studied physics at Imperial College, after which he earned a PhD in computational neuroscience from the University of Edinburgh. He has worked as a biomedical software engineer at the Icahn Genomics Institute and he has conducted the largest placebo-controlled study on psychedelics to date. In his research, Dr. Szigeti uses novel statistical and experimental techniques to explore the intersection of psychedelics and placebo effects.
Read MoreIn this episode, Dr. Fadiman answers listener-submitted questions regarding microdosing psilocybin and LSD. He discussed dosing recommendations, tolerance, microdosing's general effects on healthy normals, and its specific effects on a number of conditions, ranging from depression to PMS. He also covered a variety of additional areas where people benefit from microdosing, including academic performance and athletics.
Read MoreOn today’s history and legality of LSD episode, we’re joined by Dr. Erika Dyck. As a professor in the Department of History at the University of Saskatchewan, Dr. Dyck focuses her research on 20th Century medical history with a particular interest in psychedelics, psychiatry, eugenics, and population control. Her books include Psychedelic Psychiatry: LSD from Clinic to Campus. She is also editor of A Culture’s Catalyst and Psychadelic Prophets.
Read MoreDr. Katrin Preller has worked for the University of Zurich where she investigated the neurobiological long-term effects of cocaine, MDMA, and heroin use. She also investigated the use of psychedelics on self-perception and social cognition at the neuro-psychopharmacology and brain imaging lab. She was appointed as the junior group leader at the University of Zurich and holds a position as a visiting assistant professor at Yale University.
Read More